Atlas Trials

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Clinical trial NCT07515027 · RECRUITING

Trial details

NCT number
NCT07515027
Sponsor
Shanghai Chest Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
PONV
Start date
2026-04-07
Primary completion
2026-11-01
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.